Target
Cyclooxygenase-1 (COX-1)
11 abstracts
Abstract
REPROGRAM-02: A phase II-III study evaluating an induction treatment with regorafenib and metronomic chemotherapy before the second line chemotherapy in metastatic colorectal cancer.Org: University of Besançon, Etablissement Français du Sang Bourgogne Franche-Comté, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Hôpital Henri-Mondor, AP-HP - Université de Paris Est,
Abstract
Correlation of stress, depression, sleep, and pain with race and body mass index (BMI): Secondary analysis from Alliance A011502.Org: Roswell Park Comprehensive Cancer Center, Mayo Clinic, Channing Laboratory, Johns Hopkins Kimmel Cancer Center, Sweetwater Regional Cancer Center,
Abstract
Randomized double-blind, placebo-controlled study of topical diclofenac in prevention of hand-foot syndrome in patients receiving capecitabine.Org: All India Institute of Medical Sciences, Dr. Brairch, Abbisko Therapeutics, Department of Medical Oncology, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, All India Institute of Medical Science (AIIMS),
Abstract
Evaluation of ICI sensitivity for pembrolizumab in combination with anti-platelet therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (HNSCC).Org: The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center and Pelotonia Institute for Immuno-Oncology, Columbus, OH, Columbus, OH, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC,
Abstract
Associating patient perceptions to poor uptake of aspirin (ASA) chemoprevention in a single-center cohort of patients with Lynch syndrome (LS).Org: Crozer-Chester Medical Center, Fox Chase Cancer Center,
Abstract
Augmented curation of disease diagnoses and medications for patients with hepatocellular carcinoma.Org: nference, nference Labs,
Abstract
Effect on in-hospital outcomes of patients with hepatocellular carcinoma on aspirin.Org: University of Arizona, Liver Institute Northwest, University of California San Francisco- Fresno, Dayanand Medical College & Hospital, Punjab Institute of Medical Sciences,
Abstract
3D open-top light-sheet microscopy and 3D microdissection of neuoadjuvant-treated primary prostate cancer reveals latent subclonal mutations.Org: University of Washington and Fred Hutchinson Cancer Research Centre, Allen Brain Institute, Fred Hutchinson Cancer Center/Division of Hematology and Oncology,
Abstract
Non-vitamin k oral antagonists versus aspirin for primary thromboprophylaxis in patients with multiple myeloma on outpatient chemotherapy: A systematic review and meta-analysis.Org: Federal University of Ceará, Fortaleza, Brazil, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, Federal University of Campina Grande, Cardiff University School of Medicine,
Abstract
Knowledge gaps and educational needs for common cancer therapy-related cardiovascular toxicities and related drug interactions.Org: UNC Eshelman School of Pharmacy, Duke University Medical Center, Baptist Health Systems, North Memorial Hill Health, Baghdad Heart Center,
Abstract
Nationwide phase II randomized controlled trial of low-dose ibuprofen vs placebo for cancer-related cognitive impairment (CRCI).Org: University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, NY, University of Rochester Medical School, AdventHealth Orlando,